Henry Schein Newsroom

Baird Upgrades Henry Schein to Outperform From Neutral, Adjusts Price Target to $92 From $81

MT NewswiresJul 22 06:02 ET

Henry Schein Analyst Ratings

BenzingaJul 22 05:59 ET

Morgan Stanley Adjusts Henry Schein's Price Target to $60 From $65

MT NewswiresJul 12 09:23 ET

Henry Schein (HSIC) Gets a Sell From Morgan Stanley

TipRanksJul 12 08:34 ET

Henry Schein Analyst Ratings

BenzingaJul 9 11:43 ET

Henry Schein Analyst Ratings

BenzingaJul 5 09:57 ET

Maintained OUTPERFORM Rating for Henry Schein Amidst Recovery and Growth Prospects

TipRanksJul 5 09:27 ET

Henry Schein Analyst Ratings

BenzingaJun 21 13:48 ET

Piper Sandler Reiterates Overweight on Henry Schein, Maintains $86 Price Target

BenzingaJun 21 13:48 ET

Henry Schein Analyst Ratings

BenzingaMay 8 13:17 ET

Barrington Research Maintains Outperform on Henry Schein, Raises Price Target to $92

BenzingaMay 8 13:16 ET

UBS Adjusts Price Target on Henry Schein to $80 From $82, Maintains Neutral Rating

MT NewswiresMay 8 10:30 ET

Henry Schein Analyst Ratings

BenzingaMay 8 09:38 ET

UBS Maintains Neutral on Henry Schein, Lowers Price Target to $80

BenzingaMay 8 09:36 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Henry Schein (HSIC) and Esperion (ESPR)

TipRanksMay 8 09:25 ET

Barrington Ups Price Target on Henry Schein to $92 From $90, Maintains Outperform Rating

MT NewswiresMay 8 09:18 ET

Goldman Sachs Adjusts Price Target on Henry Schein to $74 From $76

MT NewswiresMay 8 07:41 ET

Baird Adjusts Price Target on Henry Schein to $81 From $83, Maintains Neutral Rating

MT NewswiresMay 8 06:20 ET

Henry Schein Sell Rating Affirmed Amidst Cybersecurity Woes and Execution Risks

TipRanksMay 8 05:35 ET

Henry Schein: Strong Q1 Earnings but Uncertain Outlook Warrants Hold Rating

TipRanksMay 8 00:00 ET